Market Tracker

03/23 4:45pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

13.06
Delayed Data
As of Mar 23
 -0.19 / -1.43%
Today’s Change
12.45
Today|||52-Week Range
19.35
-30.38%
Year-to-Date
3 Biotech Stocks to Buy in March
Mar 10 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close13.25
Today’s open13.25
Day’s range13.01 - 13.30
Volume186,539
Average volume (3 months)311,294
Market cap$569.0M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-2,514.29%
Earnings growth (this year)+20.35%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+41.78%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc-0.40-1.96%
BSTCBiospecifics Technol...-1.25-2.37%
AMRNAmarin Corporation P...-0.04-1.26%
AVXLAnavex Life Sciences...+0.25+4.36%
Data as of 3:59pm ET, 03/23/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$570.5M
Annual profit (last year)-$70.2M
Net profit margin-12.30%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts